Breast Cancer Treatment: What’s the Latest?

Not only are more effective drugs for breast cancer coming to the clinic, but oncologists are making important progress in matching breast cancer treatment to specific patients and the molecular characteristics of their tumors. It’s also becoming more feasible to rachet the intensity of treatment up or down depending on the patient’s risk status, and … Read more

Voices Podcast – Season 2 Episode #1: Then and Now with Lymphoma and Breast Cancer Survivor Catherine Goff

When Catherine Goff was diagnosed with Hodgkin lymphoma while attending college in the 1970s, it was the shock of a lifetime. Less surprising – but still life-changing – was her later diagnosis with breast cancer, a common secondary cancer for patients like Goff who received high doses of radiation therapy to the chest. Between these … Read more

Your Style After Breast Surgery: Ten Tips When Considering Breast Prostheses

Just as there are many types of breast-conserving surgery or reconstruction available to cancer patients after mastectomies or lumpectomies, there are a variety of considerations for those who – after consultation with their oncologist – decide to forego more surgery and wear breast prostheses (or breast forms and partial shapers). Diagnosed with triple-negative breast cancer … Read more

Who Needs Chemotherapy after Treatment for Early Breast Cancer?

Following surgery and/or radiation for early stage breast cancer, chemotherapy is sometimes given to eliminate remaining cancer cells that could cause trouble later. Traditionally, women have been more likely to undergo follow-up chemotherapy if clinical and pathological factors suggested a significant risk of recurrence, such as a larger tumor, higher stage and pathological grade of … Read more

For Metastatic Breast Cancer Patient, DF/BWCC Milford ‘Feels Like Family’

As a breast cancer survivor living an hour away from Boston, Deb Ragosta was thrilled when Milford Regional Medical Center – located just a few minutes from her Hopedale, Mass., home – became affiliated with Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) in 2008. While she had completed active treatment in 1995, she knew the partnership … Read more

A New Approach to Understanding Breast Cancer Treatment Resistance

By Srivani Ravoori, PhD, American Association for Cancer Research This post first appeared on the Cancer Today website. In a study presented Dec. 7 at the San Antonio Breast Cancer Symposium, researchers conducted genomic analysis of estrogen receptor (ER)-positive metastatic breast cancer samples that had become resistant to therapies. They found multiple alterations that were not … Read more

What Are Aromatase Inhibitors?

Aromatase inhibitors are drugs given to patients with hormone-receptor-positive breast cancer (HR+). They target the aromatase enzyme, which helps produce female hormones such as estrogen. Estrogen drives the growth of many HR+ tumors, and these drugs help control estrogen production, says Harold Burstein, MD, PhD, a breast cancer specialist in the Susan F. Smith Center … Read more